The cytotoxicity evaluation of magnetic iron oxide nanoparticles on human aortic endothelial cells

Nanoscale Research Letters

Volumn 8, Issue 1, 2013, Pages 1-10

  Ge, Gaoyuan ^a   Wu, Hengfang ^a   Xiong, Fei ^b   Zhang, Yu ^b   Guo, Zhirui ^c   Bian, Zhiping ^a   Xu, Jindan ^a   Gu, Chunrong ^a   Gu, Ning ^b   Chen, Xiangjian ^a   Yang, Di ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Southeast University   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Cell viability; Endothelial cells; Iron oxide; Magnetic nanoparticles

Indexed keywords

BLOOD VESSEL PROSTHESES; BLOOD VESSELS; CELL DEATH; CYTOTOXICITY; ENDOTHELIAL CELLS; GENES; HEMATITE; IRON OXIDES; NANOPARTICLES; POLYMERASE CHAIN REACTION; UREA;

ANGIOGENESIS; CELL VIABILITY; DIMERCAPTOSUCCINIC ACIDS; HUMAN AORTIC ENDOTHELIAL CELLS; INFLAMMATORY RESPONSE; LACTATE DEHYDROGENASE; MAGNETIC IRON OXIDE NANOPARTICLES; MAGNETIC NANO-PARTICLES;

NANOMAGNETICS;

EID: 84878755550     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-8-215     Document Type: Article

References (41)

1. Sjogren CE, Johansson C, Naevestad A, Sontum PC, Briley-Saebo K, Fahlvik AK: Crystal size and properties of superparamagnetic iron oxide (SPIO) particles. Magn Reson Imaging 1997, 15:55-67.
2. Halbreich A, Roger J, Pons JN, Geldwerth D, Da Silva MF, Roudier M, Bacri JC: Biomedical applications of maghemite ferrofluid. Biochimie 1998, 80:379-390.
3. Perez JM, O'Loughin T, Simeone FJ, Weissleder R, Josephson L: DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. J Am Chem Soc 2002, 124:2856-2857.
4. Dyal A, Loos K, Noto M, Chang SW, Spagnoli C, Shafi KV, Ulman A, Cowman M, Gross RA: Activity of Candida rugosa lipase immobilized on gamma-Fe2O3magnetic nanoparticles. J Am Chem Soc 2003, 125:1684-1685.
5. Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lubbe AS: Locoregional cancer treatment with magnetic drug targeting. Cancer Res 2000, 60:6641-6648.
6. Vasir JK, Labhasetwar V: Targeted drug delivery in cancer therapy. Technol Cancer Res Treat 2005, 4:363-374.
7. Zhang R, Wang X, Wu C, Song M, Li J, Lv G, Zhou J, Chen C, Dai Y, Gao F, Fu D, Li X, Guan Z, Chen B: Synergistic enhancement effect of magnetic nanoparticles on anticancer drug accumulation in cancer cells. Nanotechnology 2006, 17:3622-3626.
8. Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J: Magnetic nanoparticles for drug delivery. Nano Today 2007, 2:22-32.
9. Dandamudi S, Campbell RB: The drug loading, cytotoxicty and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 2007, 28:4673-4683.
10. Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefner N, Teichgraeber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, von Deimling A, Felix R: The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 2006, 78:7-14.
11. Ito A, Shinkai M, Honda H, Kobayashi T: Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther 2001, 8:649-654.
12. Moroz P, Jones SK, Gray BN: Magnetically mediated hyperthermia: current status and future directions. Int J Hyperthermia 2002, 18:267-284.
13. Kawashita M, Tanaka M, Kokubo T, Inoue Y, Yao T, Hamada S, Shinjo T: Preparation of ferrimagnetic magnetite microspheres for in situ hyperthermic treatment of cancer. Biomaterials 2005, 26:2231-2238.
14. Chen L, Bao CC, Yang H, Li D, Lei C, Wang T, Hu HY, He M, Zhou Y, Cui DX: A prototype of giant magnetoimpedance-based biosensing system for targeted detection of gastric cancer cells. Biosens Bioelectron 2011, 26:3246-3253.
15. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R: Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000, 18:410-414.
16. Kircher MF, Rhea JT, Kihiczak D, Novelline RA: Frequency, sensitivity, and specificity of individual signs of diverticulitis on thin-section helical CT with colonic contrast material: experience with 312 cases. AJR Am J Roentgenol 2002, 178:1313-1318.
17. Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Sze R, Hallahan A, Olson J, Zhang M: Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005, 5:1003-1008.
18. Jun YW, Huh YM, Choi JS, Lee JH, Song HT, Kim S, Yoon S, Kim KS, Shin JS, Suh JS, Cheon J: Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 2005, 127:5732-5733.
19. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI: Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ Health Perspect 2007, 115:403-409.
20. Muller K, Skepper JN, Posfai M, Trivedi R, Howarth S, Corot C, Lancelot E, Thompson PW, Brown AP, Gillard JH: Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials 2007, 28:1629-1642.
21. Wilhelm C, Gazeau F, Bacri JC: Magnetophoresis and ferromagnetic resonance of magnetically labeled cells. Eur Biophys J 2002, 31:118-125.
22. Billotey C, Wilhelm C, Devaud M, Bacri JC, Bittoun J, Gazeau F: Cell internalization of anionic maghemite nanoparticles: quantitative effect on magnetic resonance imaging. Magn Reson Med 2003, 49:646-654.
23. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F: Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003, 24:1001-1011.
24. Pisanic TR 2nd, Blackwell JD, Shubayev VI, Finones RR, Jin S: Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007, 28:2572-2581.
25. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Schmidt AM, Stern DM: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
26. Pober JS, Min W, Bradley JR: Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2009, 4:71-95.
27. Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D: Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 2004, 94:370-376.
28. Winn RK, Harlan JM: The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost 2005, 3:1815-1824.
29. Gu X, Yao Y, Cheng R, Zhang Y, Dai Z, Wan G, Yang Z, Cai W, Gao G, Yang X: Plasminogen K5 activates mitochondrial apoptosis pathway in endothelial cells by regulating Bak and Bcl-x(L) subcellular distribution. Apoptosis 2011, 16:846-855.
30. Donnini D, Perrella G, Stel G, Ambesi-Impiombato FS, Curcio F: A new model of human aortic endothelial cells in vitro. Biochimie 2000, 82:1107-1114.
31. Zhang S, Chen X, Gu C, Zhang Y, Xu J, Bian Z, Yang D, Gu N: The effect of iron oxide magnetic nanoparticles on smooth muscle cells. Nanoscale Res Lett 2008, 4:70-77.
32. Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, Hoebeke J, Duguet E, Colombo P, Couvreur P: Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem 2005, 16:1181-1188.
33. Gupta AK, Berry C, Gupta M, Curtis A: Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobioscience 2003, 2:255-261.
34. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
35. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
36. Chopra J, Joist JH, Webster RO: Loss of 51chromium, lactate dehydrogenase, and 111indium as indicators of endothelial cell injury. Lab Invest 1987, 57:578-584.
37. Xiao S, Wagner L, Mahaney J, Baylis C: Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells. Am J Physiol Renal Physiol 2001, 280:F989-F995.
38. Lee YW, Kuhn H, Hennig B, Toborek M: IL-4 induces apoptosis of endothelial cells through the caspase-3-dependent pathway. FEBS Lett 2000, 485:122-126.
39. Ferrari G, Terushkin V, Wolff MJ, Zhang X, Valacca C, Poggio P, Pintucci G, Mignatti P: TGF-beta1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38beta to proapoptotic p38alpha. Mol Cancer Res 2012, 10:605-614.
40. Ellis LM, Liu W, Ahmad SA, Fan F, Jung YD, Shaheen RM, Reinmuth N: Overview of angiogenesis: biologic implications for antiangiogenic therapy. Semin Oncol 2001, 28:94-104.
41. Kerbel RS: Tumor angiogenesis: past, present and the near future. Carcinogenesis 2000, 21:505-515.